Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Kenneth W Mahaffey Graeme J. Hankey Manesh Patel Keith Fox Werner Hacke Scott D Berkowitz Yuliya Lokhnygina ROCKET AF Steering Committee and Investigators Günter Breithardt Daniel E. Singer Jonathan L. Halperin Samuel M Lindner Jonathan P. Piccini Christopher C Nessel Christopher B Fordyce Richard C Becker Anne S Hellkamp |
| Publication date | March 1, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |